Purchase Order 75N92E20K20010
Award Date 9/4/20
Potential Completion Date 9/29/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $127,989.57 firm fixed-price delivery order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing technologies. The contract has a period of performance ending on July 30, 2026. Illumina, a for-profit manufacturer, has been awarded multiple federal contracts and blanket purchase agreements to provide a range of genomic sequencing platforms,...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
- This firm fixed-price delivery order contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and bioinformatics products. The $131,931.29 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related goods and services to support genomic research and analysis. This award is not associated with a set-aside...
- This is a $77,550 firm fixed-price delivery order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract does not have a set-aside designation. The contract provides Illumina's advanced DNA and RNA sequencing instruments, reagents, consumables, maintenance services, and bioinformatics...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $195,464.40 contract provides for Illumina Sequencers Service Agreement, which includes the procurement of advanced sequencing instruments like NextSeq, NovaSeq, MiSeq, and iSeq systems, along with associated reagents,...
- This is a $164,633.80 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously held prime contracts and subcontracts with various federal agencies...
- This federal contract award is a $24,256 firm fixed price delivery order placed with Illumina, Inc., a for-profit biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract was awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health (NIH), with a period of performance ending on August 31, 2015. The contract does not have a set-aside designation. Illumina has been awarded multiple federal...
- This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $44,187.38 contract is for the provision of Illumina's sequencing systems, reagents, and related consumables and services to support genomic research and analysis activities. The contract has no set-aside designation and is not associated with a larger acquisition vehicle. Illumina, a manufacturer of genetic and...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $21,323.61 contract is for the provision of various Illumina sequencing systems, reagents, and related maintenance services to support genomic research and analysis across federal agencies. Illumina has a history of prime federal contract awards...